Abstract:Abstract Diphthamide is a modified histidine residue unique for eukaryotic translation elongation factor 2 (eEF2), a key ribosomal protein. Loss of this evolutionarily conserved modification causes developmental defects through unknown mechanisms. In a patient with compound heterozygous mutations in Diphthamide Biosynthesis 1 ( DPH1 ) and impaired eEF2 diphthamide modification, we observe multiple defects in neural crest (NC)-derived tissues. Knockin mice harboring the patient’s mutations and Xenopus embryos with Dph1 depleted also display NC defects, which can be attributed to reduced proliferation in the neuroepithelium. DPH1 depletion facilitates dissociation of eEF2 from ribosomes and association with p53 to promote transcription of the cell cycle inhibitor p21, resulting in inhibited proliferation. Knockout of one p21 allele rescues the NC phenotypes in the knockin mice carrying the patient’s mutations. These findings uncover an unexpected role for eEF2 as a transcriptional coactivator for p53 to induce p21 expression and NC defects, which is regulated by diphthamide modification.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how diphthamide deficiency affects the development of neural crest (NC) cells and to reveal the underlying molecular mechanisms. Specifically, the study focused on the developmental defects caused by compound heterozygous mutations in the diphthamide - synthesizing gene DPH1, especially the defects in neural crest - derived tissues. By analyzing a DEDSSH1 patient carrying these mutations and using mouse and Xenopus laevis embryo models, the researchers found that diphthamide deficiency promotes the binding of eEF2 to p53, thereby promoting p21 expression, inhibiting cell proliferation, and leading to abnormal development of neural crest cells. In addition, the study also explored whether reducing p21 expression could partially rescue the developmental defects caused by DPH1 loss - of - function. ### Main problems and research methods 1. **Problem background**: - Diphthamide is a modification only present on eukaryotic translation elongation factor 2 (eEF2) and is crucial for cell function. - The DPH1 gene encodes an enzyme involved in diphthamide synthesis, and its mutations are associated with diseases such as developmental retardation, craniofacial malformations, and growth hormone deficiency (e.g., DEDSSH1). 2. **Research objectives**: - To explore how diphthamide deficiency caused by DPH1 mutations affects the development of neural crest cells. - To reveal the specific molecular mechanisms of diphthamide deficiency, especially the interaction between eEF2 and p53 and its impact on p21 expression. 3. **Research methods**: - **Clinical analysis**: Analyze the clinical phenotype and genetic background of a patient carrying DPH1 compound heterozygous mutations. - **Cell experiments**: Use lymphoblast - like cell lines to detect the effect of DPH1 mutations on eEF2 diphthamide modification. - **Animal models**: Construct a mouse model (KI mouse) carrying patient mutations and observe its developmental phenotype. - **Xenopus laevis embryo model**: Knock out the dph1 gene by CRISPR/Cas9 technology and observe the development of neural crest cells. - **Molecular biology experiments**: Explore the interaction between eEF2 and p53 and its impact on p21 expression by methods such as co - immunoprecipitation (Co - IP) and chromatin immunoprecipitation quantitative PCR (ChIP - qPCR). ### Main findings 1. **Diphthamide deficiency affects neural crest cell development**: - Patients carrying DPH1 mutations show defects in neural crest - derived tissues, such as sparse hair, craniofacial malformations, etc. - In mouse and Xenopus laevis models, the deletion of the dph1 gene leads to a decrease in neural crest cell proliferation and similar developmental defects. 2. **Interaction between eEF2 and p53**: - Diphthamide deficiency causes eEF2 to dissociate from the ribosome and enhances its binding to p53. - The binding of eEF2 to p53 promotes the transcription of the p21 gene, which in turn inhibits cell proliferation. 3. **Reducing p21 expression partially rescues developmental defects**: - By deleting one p21 allele, some of the mouse developmental defects caused by DPH1 loss - of - function, including reduced body size and cleft palate, were partially rescued. ### Conclusion This study reveals the important role of diphthamide modification in the development of neural crest cells, especially in affecting p21 expression by regulating the interaction between eEF2 and p53, thereby controlling cell proliferation. This finding not only deepens the understanding of genetic diseases such as DEDSSH1 but also provides new ideas for potential treatment strategies.

Diphthamide deficiency promotes association of eEF2 with p53 to induce p21 expression and neural crest defects

Inhibition of Nonsense-Mediated Decay Rescues Functional P53β/γ Isoforms in MDM2-amplified Cancers

Dp53 Restrains Ectopic Neural Stem Cell Formation in the Drosophila Brain in a Non-Apoptotic Mechanism Involving Archipelago and Cyclin E.

WDR34 Mutation from Anencephaly Patients Impaired Both SHH and PCP Signaling Pathways

Spliceosomal Protein Eftud2 Mutation Leads to P53-Dependent Apoptosis in Zebrafish Neural Progenitors

EFTUD2 gene deficiency disrupts osteoblast maturation and inhibits chondrocyte differentiation via activation of the p53 signaling pathway

Microcephaly Gene Mcph1 Deficiency Induces p19ARF-Dependent Cell Cycle Arrest and Senescence

Double whammy: the genetic variants in CECR2 and high Hcy on the development of neural tube defects

Folate deficiency reduced aberrant level of DOT1L-mediated histone H3K79 methylation causes disruptive SHH gene expression involved in neural tube defects

Synergistic regulation of p53 by Mdm2 and Mdm4 is critical in cardiac endocardial cushion morphogenesis during heart development.

Zebrafish models for dyskeratosis congenita reveal critical roles of p53 activation contributing to hematopoietic defects through RNA processing.

Persistent TFIIH binding to non-excised DNA damage causes cell and developmental failure

Diphthamide Biosynthesis 1 is a Novel Oncogene in Colorectal Cancer Cells and is Regulated by MiR-218-5p

Identification of Novel Rare Mutations of DACT1 in Human Neural Tube Defects.

E2F1 Regulates P53r2 Gene Expression in P53-Deficient Cells

Phosphorylation Of Def Regulates Nucleolar P53 Turnover And Cell Cycle Progression Through Def Recruitment Of Calpain3

p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage

MTHFD1 is critical for the negative regulation of retinoic acid receptor signalling in anencephaly

Disease modeling of core pre-mRNA splicing factor haploinsufficiency

Mcph1, mutated in primary microcephaly, is also crucial for erythropoiesis

Identification and functional analysis of rare HECTD1 missense variants in human neural tube defects